New England Research & Management’s Comerica CMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,682
Closed -$1.16M 154
2025
Q1
$1.16M Buy
19,682
+7,007
+55% +$440K 0.59% 58
2024
Q4
$784K Buy
+12,675
New +$824K 0.4% 79
2023
Q1
Sell
-11,575
Closed -$774K 146
2022
Q4
$774K Buy
+11,575
New +$802K 0.44% 81
2022
Q1
Sell
-6,475
Closed -$563K 168
2021
Q4
$563K Buy
6,475
+850
+15% +$72.9K 0.27% 103
2021
Q3
$453K Buy
+5,625
New +$405K 0.24% 113
2018
Q3
Sell
-3,100
Closed -$282K 163
2018
Q2
$282K Buy
+3,100
New +$297K 0.19% 136
2015
Q2
Sell
-6,275
Closed -$283K 175
2015
Q1
$283K Sell
6,275
-700
-10% -$31.2K 0.24% 137
2014
Q4
$327K Sell
6,975
-4,825
-41% -$227K 0.28% 134
2014
Q3
$588K Buy
+11,800
New +$592K 0.51% 85

Other funds holding CMA

New England Research & Management's CMA Position: Q2 2025 in Review

New England Research & Management sold out of Comerica (CMA) in Q2 2025, closing a stake of 19,682 shares — an estimated $1.16M sold.

New England Research & Management first reported a position in CMA in Q3 2014 and held it in 9 quarters. The position peaked at $1.16M in Q1 2025. 532 funds tracked by Wall St. Rank hold CMA as of Q2 2025.

  • New England Research & Management reported no remaining Comerica position as of Q2 2025 after selling out during the quarter.
  • New England Research & Management sold 19,682 Comerica shares in Q2 2025, an estimated $1.16M.
  • New England Research & Management first reported a position in Comerica in Q3 2014 and held it in 9 quarters.
  • New England Research & Management's Comerica position peaked at $1.16M in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Comerica as of Q2 2025.

Based on New England Research & Management's 13F filing for Q2 2025, filed 9 Jul 2025.